Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes.

导出 OA

翻译打印收藏纠错

作者： Aleksandra,Kukulska ^[1] ; Jolanta,Krajewska ^[2] ; Marzena,Gawkowska ^[1] ; Ewa,Paliczka-Cieslik ^[3] ; Daria,Handkiewicz-Junak ^[1] ; Aleksandra,Kropińska ^[1] ; Zbigniew,Puch ^[1] ; Tomasz,Olczyk ^[1] ; Jozef,Roskosz ^[1] ; Barbara,Jarzab ^[1]

作者单位： Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. ^[1] Radiotherapy Department, M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. ^[2] Third Clinic of Radiotherapy and Chemotherapy, M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. ^[3]

关键词 differentiated thyroid cancer low-risk thyroid cancer radioiodine radioiodine activity radioiodine treatment remnant ablation

DOI 10.5114/aoms.2020.97803

PMID 36160333

发布时间 2022-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交